Ensemble, améliorons la qualité en santé

Home > English

Search

There are 1,161 results - Search

Sort by: Relevance - Title - Date - Type

Hide summaries

< [1] 2 3 4 5 ... >
1. LAMICTAL-LAMICSTART - CT 7616 - English version
93.54 Ko -  Online on 4/5/2012
2. STELARA - CT 6336 - English version
125.85 Ko -  Online on 4/5/2012
3. YONDELIS - CT 7917 - English version
55.78 Ko -  Online on 4/5/2012
4. YONDELIS
Date 16/6/2010
Inclusion on the list of medicines approved for hospital use in extension of indication “in combination with pegylated liposomal doxorubicin (PLD) in the treatment of platinum-sensitive recurring ovarian cancer”.
Opinions on drugs  - Online on 4/5/2012
5. LAMICTAL-LAMICSTART
Date 5/5/2010
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use in the extension of indication for adults aged 18 years and older: “Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes. Lamictal is not indicated for the acute treatment of manic or depressive episodes."
Opinions on drugs  - Online on 4/5/2012
6. STELARA
Date 13/5/2009
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital and various public services use.
Opinions on drugs  - Online on 4/5/2012
7. RASILEZ - CT 6371 - English version
53.26 Ko -  Online on 26/4/2012
8. RASILEZ
Date 27/5/2009
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Opinions on drugs  - Online on 26/4/2012
9. MULTIHANCE - CT 6105 - English version
84.91 Ko -  Online on 20/4/2012
10. CARDIOCOR - CT 6670 - English version
48.12 Ko -  Online on 18/4/2012
11. COOLMETEC - CT 8103 - English version
59.06 Ko -  Online on 18/4/2012
12. EZETROL - CT 6429 - English version
126.3 Ko -  Online on 18/4/2012
13. INEGY - CT 6442 - English version
120.37 Ko -  Online on 17/4/2012
14. Programme_AMI_Alzheimer

Programme of the Alert and the Mastering the Iatrogenicity of Neuroleptics (NL) in the Alzheimer’s Disease (AD) October 2010 - Updating February 2011

94.49 Ko -  Online on 12/4/2012
15. ALCOVE, a European Cooperative Project focused on Alzheimer’s Disease

ALCOVE (ALzheimer COoperative Valuation in Europe) is a European Joint Action which was launched in April 2011. The project’s aim is to improve knowledge about dementia care and to work together to find the best options for preserving the quality of life, autonomy, and rights of individuals living with dementia and their carers. The HAS is in charge of the overall coordination of the project in conjunction with the French Alzheimer Plan and Ministry of Health. This coming April 12, all of the representatives of the countries participating in the project have been invited by the HAS to meet so that they may share their findings and assess their progress mid-project.

Press release  - Online on 11/4/2012
16. PARADIGM VEO system - 21 december 2010 (2711) - Opinion

Insulin pump and continuous interstitial glucose monitoring device

Opinions on products and services  - Online on 20/3/2012
17. RELAY - 14 september 2010 (2708) -Opinion

Thoracic aortic stent-graft

Opinions on products and services  - Online on 20/3/2012
18. Alzheimer's disease and iatrogenicity of antipsychotics
Web page  - Online on 21/2/2012
19. HAS Collaboratives - brochure (english version)

A participatory method for improving professional practice December 2010

167.01 Ko -  Online on 20/2/2012
20. Assessment of medical devices for home infusion

The objective of this document is to reassess the various categories of medical devices for home infusion, as well as the associated services, in order to ensure a proper basis for the renewal of their reimbursement. The reassessment had the following aims:
- to evaluate the actual benefit of medical devices for home infusion, taking into account the therapeutic effect / adverse effects ratio, the role in the therapeutic strategy and the benefit to public health of these products;
- to define the indications and clinical situations for the use of the different types of medical devices for home infusion;
- to define the ways in which these products will be listed in the List of Products and Services Qualifying for Reimbursement (LPPR);
- to determine the conditions of use and of prescription.

Health technology assessment  - Online on 8/2/2012
21. ''Full care cycles'' HAS Expert Seminar, 15th-16th December 2011 - Paris
Web page  - Online on 19/1/2012
22. HAS Expert Seminar Full care cycles_session_2_1_ALeperreDesplanques

Pathways' evaluation HAS Concept

530.16 Ko -  Online on 18/1/2012
23. Managing obesity in children and adolescents

This clinical guideline has been updated in September 2011 by the guideline 76 : " Overweight and obesity in children and adolescents September 2011"

The following issues are discussed:

  1. Definition and diagnosis of obesity
  2. Risk factors for obesity
  3. Obesity-related morbidity and mortality
  4. Assessment of treatment methods
  5. Treatment strategy
Practice guidelines  - Online on 27/12/2011
24. MRI-guided vacuum-assisted breast biopsy (VABB)

MRI-guided VABB is a breast biopsy technique used for percutaneous histologic tissue acquisition of non palpable breast lesions, only detected by MRI and having neither sonographic nor mammographic correlates. This minimally invasive needle biopsy technique reduces the need for open surgical breast biopsy in patients with benign lesions and allows for optimal preoperative work-up and surgical planning through definitive diagnosis in patients with breast cancer. Our objective was to evaluate technical success rate, safety and diagnostic effectiveness of MRI-guided VABB and determine its clinical indications for use. Specific practice and facility requirements for reimbursement in France were equally assessed

Health technology assessment  - Online on 21/12/2011
25. Alzheimer's disease and related conditions - Diagnosis and treatment

To standardise practices relating to the diagnosis and treatment (drug and non-drug interventions, follow-up) of patients suffering from Alzheimer's disease or a related condition

Practice guidelines  - Online on 16/12/2011
26. AVAXIM ADULTES - CT 8198 - English version
56.01 Ko -  Online on 9/11/2011
27. AVAXIM PEDIATRIQUE - CT 7771 - English version
77.02 Ko -  Online on 9/11/2011
28. HAVRIX ADULTES - CT 8197 - English version
73 Ko -  Online on 4/11/2011
29. HAVRIX NOURRISSONS ET ENFANTS - CT 7591 - English version
87.74 Ko -  Online on 4/11/2011
30. Impact and results of quality improvement and patient safety programmes in hospitals : HAS studies and projects
Web page  - Online on 12/10/2011
31. IMGENI study : Summary in English
772.39 Ko -  Online on 5/10/2011
32. Matrix Insight®: Summary in English
1.15 Mo -  Online on 5/10/2011
33. MOVIPREP - CT 6888 - English version
67.35 Ko -  Online on 16/9/2011
34. MOVIPREP
Date 23/9/2009
Inclusion on the list of medicines reimbursed by National Insurance and on the list of medicines approved for use by hospitals.
Opinions on drugs  - Online on 16/9/2011
35. ALTEISDUO - CT 8132 - English version
61 Ko -  Online on 8/9/2011
36. RANEXA - CT 6981 - English version
65.48 Ko -  Online on 8/9/2011
37. XILANIK - CT 7738 - English version
38.87 Ko -  Online on 18/8/2011
38. VELMETIA - CT 6479 - English version
98.37 Ko -  Online on 18/8/2011
39. ANGIOX - CT 7823 - English version
120.1 Ko -  Online on 18/8/2011
40. Surgical haemostatic agents:treatments of last resort

Leaflet on good practice in healthcare technology use

Synthèse d'avis et Fiche bon usage  - Online on 25/7/2011
41. ONYTEC - CT 7347 - English version
89.87 Ko -  Online on 13/7/2011
42. TOCTINO - CT 6204 - English version
98.46 Ko -  Online on 13/7/2011
43. VIDAZA - CT 6362 - English version
78.37 Ko -  Online on 13/7/2011
44. ARIDOL - CT 7977 - English version
88.66 Ko -  Online on 13/7/2011
45. ARIDOL
Date 16/6/2010
Inclusion on the list of medicines approved for hospital use.
Opinions on drugs  - Online on 16/6/2011
46. Selection of iron metabolism tests in cases where iron deficiency is suspected

The French health insurance agency asked the HAS to determine strategies for the use of iron metabolism markers. In fact, the volume of procedures carried out in relation to all such tests which are reimbursed by the health insurance agency increased by 109% between 2000 and 2008. Furthermore, some tests appear to be redundant or irrelevant according to the latest French recommendations, (ANDEM, 1995). In this assessment, the HAS has focused on iron deficiency and has not looked at iron overloads, since professional recommendations issued by the HAS in 2005 on haemochromatosis still appear to be valid

Health technology assessment  - Online on 14/6/2011
47. PREZISTA - CT 7149-7150 - English version
96.73 Ko -  Online on 9/6/2011
48. MODIGRAF - CT 7077 - English version
71.89 Ko -  Online on 9/6/2011
49. PREZISTA
Date 2/12/2009
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for use by hospitals.
Opinions on drugs  - Online on 9/6/2011
50. NEISVAC - CT 7129 - English version
51.87 Ko -  Online on 6/6/2011
< [1] 2 3 4 5 ... >

Tools

Refine by topic

Digestive system cancers (26) - Genital cancers (13) - Respiratory tract cancers (10) - Urologic cancers (7) - Skin and connective tissue cancers (14) - Hematologic cancers (15) - Breast cancers (16) - Nervous system cancers (1) - Cancers - miscellaneous (9) - Pain (12) - Disability (5) - Poisoning (1) - Mouth diseases (4) - Jaw diseases (1) - Tooth diseases (4) - Myocardial ischemia (12) - Heart failure (8) - Cardiac arrhythmia (6) - Heart valves diseases (2) - Heart diseases - miscellaneous (3) - Liver diseases (21) - Pancreatic and biliary tract diseases (2) - Esophageal and gastrointestinal diseases (17) - Female genital diseases (8) - Male genital diseases (5) - Joint and rheumatic diseases (32) - Musculoskeletal diseases - miscellaneous (4) - Muscular diseases (1) - Bone and cartilage diseases (9) - Bronchial diseases (8) - Pulmonary and pleural diseases (16) - Respiration disorders (4) - Eye diseases (12) - Skin and connective tissue diseases (23) - Anemia and hemoglobinopathies (1) - Bone marrow diseases (1) - Lymphatic diseases (1) - Blood coagulation and hemostasis disorders (8) - Breast diseases (2) - Allergy (4) - Immunologic deficiency syndromes (17) - Autoimmune diseases (19) - Demyelinating diseases (2) - Nervous system diseases - miscellaneous (4) - Central nervous system diseases (28) - Neurodegenerative diseases (8) - Neuromuscular diseases (4) - Diabetes mellitus (11) - Endocrine system diseases (9) - Metabolic diseases (14) - Obesity (3) - Congenital, genetic and rare diseases (32) - Bacterial infections (16) - Parasitic diseases and mycoses (3) - Virus diseases (33) - Sexually transmitted diseases (24) - Ear diseases (3) - Nose and sinus diseases (2) - Phayngeal diseases (3) - Kidney diseases (12) - Urination disorders (6) - Aneurysm and other vascular malformations (5) - Embolism, thrombosis and stenosis (13) - Hypertension (14) - Aortic diseases (3) - Vascular diseases - miscellaneous (2) - Peripheral vascular diseases (6) - Cerebrovascular disorders (7) - Alzheimer’s disease and mental disorders (3) - Depression and mood disorders (3) - Schizophrenia and delusional disorders (3) - Substance-related disorders (2) - Eating and sleep disorders (6) - Anxiety and neurotic disorders (3) - Disorders of adult personality and behaviour (1) - Disorders of psychological development (2) Medical equipement (11) - Biotherapies, transfusions, transplantations (8) - Therapeutic patient education (2) - Interventional imaging (11) - Nutrition, dietetics (6) - Anaesthesia, sedation, analgesia (1) - Cardiac surgery (5) - Gastrointestinal surgery (7) - Oromaxillofacial surgery (4) - Ophtalmologic surgery (3) - Orthopaedic surgery (9) - Otorhinolaryngologic surgery (2) - Plastic surgery (1) - Urogenital surgery (6) - Vascular surgery (9) - Neurosurgery (8) - Operative surgical procedures (2) - Protheses and implants (15) - Radiotherapy and physical agents (13) - Rehabilitation techniques (16) - Cell and tissue pathology (3) - Biology (laboratory tests) (15) - Medical imaging (27) - Diagnostic techniques and procedures - miscellaneous (1) - Telemedicine (1) - Alternative medicine (1) - Emergency treatment and intensive care (7) - Drug therapy (337) Screening, prevention (35) - Ethics (1) - Legal expertise (1) - Patients’ records (1) - Patient information and patients’ rights (9) - Organisation of care (10) - Occupational health (2)

Refine by content type
Haute Autorité de Santé - 2012